The first new type of drug for Tourette syndrome in over 50 years is close to the FDA’s doorstep
Often characterized by involuntary motor or vocal tics, Tourette syndrome typically appears in childhood and affects up to ...
Clinical Advisor1d
Novel Dopamine-1 Receptor Antagonist Shows Promise for Tourette Syndrome
By blocking dopamine-1 receptors, ecopipam is expected to reduce the repetitive and compulsive behaviors seen in Tourette syndrome.
Study finds cellular differences in Tourette patients' brain tissue
The biological roots of Tourette disorder occur in the basal ganglia, structures deep in the brain involved in the control of ...
Hosted on MSN1mon
Tourette Syndrome: Why Is It Overlooked In Girls?
The study used the Tourette Association of America International Consortium for Genetics data set to better understand sex differences and health outcomes for the neurodevelopmental disorder.
Wake Forest University School of Medicine recognized by Tourette Association of America Center of Excellence
Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist Medical Center have been recognized by the ...
Nasdaq1mon
Relmada Therapeutics Acquires Sepranolone from Asarina Pharma for Tourette Syndrome Treatment Development
Relmada Therapeutics has announced the acquisition of Sepranolone, a Phase 2b ready neurosteroid developed for treating Tourette syndrome (TS) and related compulsive disorders, from Asarina Pharma ...
BBC1y
What is it like to have Tourette’s Syndrome when you’re a teenager?
That’s exactly what happened to Georgia when she first developed Tourette’s Syndrome. Image caption, Georgia, right, was in the middle of her mock GCSE exams when she showed signs of Tourette ...
BBC1mon
Tourette’s Syndrome: ‘I didn't speak to anyone about it for 23 years'
BBC producer Isabel Kimbrey was diagnosed with Tourette’s syndrome at the age of 7, and shared how she wanted to open up the conversation about Tourette's in "the most realistic way".